ZURICH & BARCELONA, Spain--()--The seventh annual BIO-Europe Spring® international partnering conference will be held in Barcelona, Spain March 11–13, 2013 at the CCIB Convention Centre Barcelona. The event is expected to draw 2,000 attendees representing C-level executives and key decision makers from over 1,200 companies.
“The Catalonia region has the infrastructure to support a dynamic life science discovery cluster”
“The Catalonia region has the infrastructure to support a dynamic life science discovery cluster,” said Carola Schropp, President of EBD Group. “Spain’s biotechnology sector continues to grow. Barcelona’s biotech hub is interested in new public-private partnerships with international companies, and they are committed to the global pursuit of innovation in clinical research and human health.”
Host organizations for the 2013 event are Biocat, the biotechnology, biomedicine and medical technology regional incubator, and Ajuntament de Barcelona, the Barcelona City Council.
“The Barcelona region features 20 science and technology parks and 60 research centers focused on life science, notably the state-of-the-art National Genome Analysis Center, and over 450 companies in the sector,” said Montserrat Vendrell, CEO for Biocat. “The pace of biotechnology progress has really exploded here in Catalonia, and there are a number of companies with projects in Phase I and II trials who are eager to partner. We welcome the global life science to explore the opportunities that are here.”
The BIO-Europe Spring program will showcase the leading industry decision makers speaking on hot topics of interest to the life science and investment sector. The program also features the popular Therapeutic Insight by Defined Health, one of the leading strategic biopharma business development firms. This program track will have four sessions dedicated to transformative growth opportunities in leading therapeutic categories such as orphan CNS, antibiotics and oncology.
BIO-Europe Spring 2012, held in Amsterdam, The Netherlands, welcomed 2,157 delegates representing 1,304 companies vying for an estimated 2,508 licensing opportunities. 11,172 one-to-one meetings took place at that event between companies across the life science value chain, from large biotech and pharma companies to financiers and innovative start-ups.
One-to-one partnering meetings for the 2013 edition in Barcelona can be scheduled prior to the event utilizing partneringONE®, EBD Group’s leading conference networking solution. As the leading conference networking solution for the life sciences, the system generates over 40,000 one-to-one meetings at EBD Group's six life science partnering events held around the world. With partneringONE, pharma and biotech dealmakers can create a partnering profile and begin efficiently identifying and requesting meetings with potential collaborators. For more about partneringONE and how to log on to your account, go to www.ebdgroup.com/bes/partnering/index.php
Information for BIO-Europe Spring can be found online at http://www.ebdgroup.com/bes
Notes to Editors:
Entry to BIO-Europe Spring 2013 is free to members of the press, including full access to the partnering system, sessions, press conferences, workshops, and pre-arranged partnering meetings. Visit the BIO-Europe Spring conference website at http://www.ebdgroup.com/bes/press_reg.htm for registration details.
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:
- BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
- BioPharm America™, the fastest growing partnering event in North America
- Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
- BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
- ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
- EuroMedtech™, EBD Group’s partnering event for the innovative medical technology industry
- Partnering for Global Impact®, a new partnering conference providing an innovative forum to partner, identify and generate social and philanthropic investment and funding opportunities
EBD Group’s sophisticated web-based partnering service, partneringONE®, is also used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences all year long. Outside of the conference format, EBD Group’s consultants provide hands-on assistance for firms seeking to in- or out-license products and technologies.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com.